MATERIALS AND METHODS
Two hundred blood donors (125 male, 75 female) born in Northern Ireland were tissue typed for HLA-A and -B locus antigens. The number of blood donors from each county was proportional to the total population of that county. An extra 10 ml of blood from suitable donors was taken at the donor sessions into sodium citrate. The blood donors were typed within one day of bleeding.
A total of 72 Sera defining the following specificities were used: HLA -A1, A2, A3, A9, A10, All, A28, A29 HLA -B5, B7, B8, B12, B13, B14, B15, B17, B18, BW22, B27, BW35, B.40. The sera were either supplied by the National Tissue Typing Reference Laboratory, Bristol, or were sera from our own laboratory which have been tested for their activity both here and in Bristol. Typing was by a two stage 171 * Supported by a grant from the Northern Ireland Kidney Research Fund. microlymphocytotoxicity test at 22°C (Nelson and Middleton 1975) and at least 3 sera were used to define each specificity.
The antigen frequency of the Northern Ireland blood donors was compared with the antigen frequency in 1,036 blood donors from Bristol, in 342 blood donors from Glasgow and in 453 blood donors from Eire using a Yates' corrected chi-squared analysis, with a correction for the number of antigens tested (Grumet et al, 1971) .
The gene frequency of each of the antigens in the Northern Ireland blood donors was calculated using the formula p=l-(sq. rt.) 1-f where p denotes the gene frequency and f the frequency of the corresponding antigen.
The tissue types of the Northern Ireland blood donors were analysed to find out if there were any differences in the antigen frequency due to sex, age or place of birth. In the latter analysis only blood donors born in Co. Down (n=43), Co. Antrim (n=48) and Belfast (n=42) were considered, as the number of blood donors born in Counties Derry, Tyrone, Armagh and Fermanagh were considered too small for statistical analysis. For the purpose of assessing the effect of age on HLA antigen frequency we divided the blood donors into two groups, 119 aged 16-35 and 81 aged 36-65. Table 1 shows the frequency of HLA antigens in blood donors from Northern Ireland compared with the antigen frequency in blood donors from Bristol, Glasgow and Eire. Statistical differences at the 5 per cent level were found in the following antigens HLA -Al,-B7,-B8,-B14 and -B18 with Bristol, -All with Glasgow and -B12 with Dublin. Only one difference, HLA -B14 in the comparison with Bristol blood donors, is still significant after multiplying the initial P value by a factor off 21, the number of comparisons made between the two populations. In the latter two comparisons only one antigen frequency in each, HLA -All and -B12 respectively, was significant at the 5 per cent level. By definition, out of 20 comparisons, on the average, we would expect one of them to be significant at the 5 per cent level. When we multiplied the initial P value for the two significant comparisons by a factor of 21 (the number of camparisons made) we found that in neither case was it still significant. However in the comparison of HLA antigen frequency in donors from Northern Ireland with those of Bristol we found that five antigen frequencies HLA -Al,B7,-B8,-B14 and -B18 differed significantly. One of these, HLA -B14, was still significant after correction for the number of comparisons made. These differences are unlikely to be due to the sera which have been well defined both here and at the National Tissue Typing Reference Laboratory, Bristol. Our number of blood donors tested (200) is much smaller than the number tested in Bristol (1,036) and this could be one of the reasons for the difference in frequencies between the two centres.
RESULTS
Our finding that a blood donor population from Northern Ireland has a very similar HLA antigen frequency to a blood donor population from Glasgow and from Eire but varies significantly in five antigens from a Bristol blood donor population, agrees with the ABO distribution of blood donors from these areas (see Table 3 ). Also, although the population of Northern Ireland at the moment is stable it is made up of two distinct origins -the Irish Gaelic and the Ulster Scot.
Our results show the necessity of using people born in Northern Ireland as a control group when examining the HLA antigen frequency of people with a particular disease. For example, to have used the Bristol blood donor HLA frequency as controls in our study on patients with a Plummer-Vinson stricture would have led us to believe that HLA -B8 was significantly more frequent in the patients than in the controls, whereas this is not the case when we use controls from Northern Ireland (Middleton et al. 1978 ).
* Taken from Kopec. t Taken from Dawson. We have compared the variation in HLA antigen frequency in two age groups. There are no significant differences after correction in the groups suggesting that although some HLA antigens are associated with disease these effects neutralise each other in the population. Previous findings have shown that older people have a larger number of HLA specificities than young people (Gerkin et al. 1974 , Bender et al 1973 . Like ourselves other recent studies have failed to confirm this (Albert et al. 1974 , Murcurova et al. 1975 . In our study the average number of HLA specificities per person below 36 was 3.387 and the average in the 36-65 age group was 3.309.
Requests to us for tissue typing relatives of prospective platelet recipients have recently increased. It is very difficult to obtain a full house match for these recipients from their relatives. Having a panel of potential platelet donors should make it easier to obtain a perfect match for these platelet recipients. SUMMARY Histocompatibility (HLA) antigen testing of 200 normal donors was performed to provide a baseline for studies on the HLA antigen frequency of patients with diseases. The results were compared with similar results from Bristol, Eire and Glasgow. The Belfast HLA antigen frequencies closely resembled the results from Eire and Glasgow but showed marked differences from Bristol. This finding corresponds to ABO blood group distribution. Our tissue typed blood donors can now be used as platelet donors if required.
